Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
HAYWARD, Calif., July 9, 2012 /PRNewswire/ — Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced that Paul F. Truex, Anthera’s President and Chief Executive Officer, will present the company’s corporate overview on Friday, July 13, 2012, at 1:30 pm Eastern Time (10:30 am Pacific Time) during the 7th Annual JMP Securities Healthcare Conference at the Peninsula New York Hotel in New York City.
About Anthera Pharmaceuticals
Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.
CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., firstname.lastname@example.org or 510.856.5586.
SOURCE Anthera Pharmaceuticals, Inc.